Clinical trials for Primary biliary cholangitis
39 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGNCT07449793Biochemical Response and Clinical Outcomes in Patients With PBCRenJi Hospital · PI: Xiong Ma, MD, PhD
- RECRUITINGPhase 3NCT07296458FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC TherapyXijing Hospital of Digestive Diseases
- RECRUITINGPhase 3NCT07282353A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCACascade Pharmaceuticals, Inc · PI: Ma Xiong, MD
- RECRUITINGNCT07205874Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP)Hospital Universitario La Paz
- ACTIVE NOT RECRUITINGNCT07049887A Study Describing Scratch and Sleep Patterns in Patients With Primary Biliary Cholangitis (Luminaria)Ipsen · PI: Ipsen Medical Director
- RECRUITINGNCT07149675PBC Long-term Outcomes StudyBeijing Friendship Hospital
- RECRUITINGEarly Phase 1NCT07104201Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)Xijing Hospital of Digestive Diseases
- RECRUITINGN/ANCT06861465EMPower MechanismsUniversity of Alberta
- RECRUITINGN/ANCT07161245RELIEF: Multimodal Prehabilitation to Treat Fatigue in Patients With Primary Biliary CholangitisHospital Clinic of Barcelona · PI: Sergio Rodríguez Tajes, MD, PhD
- RECRUITINGNCT06675604LEOPARD Training and Validation Data Collection StudyAssistance Publique - Hôpitaux de Paris
- ACTIVE NOT RECRUITINGPhase 3NCT06730061A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)Ipsen · PI: Ipsen Medical, Director
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT06591468A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis With Moderate to Severe Interface Hepatitis CharacteristicsHan Ying
- RECRUITINGNCT06447168A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing TreatmentIpsen · PI: Ipsen Medical Director
- ACTIVE NOT RECRUITINGNCT06604923PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Changes in the Hepatobiliary System in Patients With Primary Biliary Cholangitis Before and After Treatment.University of Aarhus
- RECRUITINGPhase 3NCT06427395Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary CholangitisZydus Therapeutics Inc. · PI: Deven Parmar
- ACTIVE NOT RECRUITINGPhase 3NCT06383403A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.Ipsen · PI: Ipsen Medical Director
- ACTIVE NOT RECRUITINGPhase 2NCT06247735Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.Kowa Research Institute, Inc. · PI: Andre Belous, MD, PhD
- RECRUITINGPhase 3NCT06755541Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World StudyXijing Hospital of Digestive Diseases
- RECRUITINGPhase 3NCT06755151Fenofibrate in Primary Biliary Cholangitis: a Real World StudyXijing Hospital of Digestive Diseases
- RECRUITINGPhase 3NCT06051617Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated CirrhosisGilead Sciences · PI: Gilead Study Director
- ACTIVE NOT RECRUITINGPhase 3NCT06060665Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)Gilead Sciences · PI: Gilead Study Director
- RECRUITINGPhase 3NCT06016842A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary CholangitisIpsen · PI: Ipsen Medical Director
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT06174402Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary CholangitisHan Ying
- ACTIVE NOT RECRUITINGPhase 2NCT05896124CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)Cascade Pharmaceuticals, Inc · PI: Rong Deng
- RECRUITINGNCT05919433Detection Program for Patients With Primary Biliary Cholangitis Lost in the SystemHospital Mutua de Terrassa
- RECRUITINGPHASE1, PHASE2NCT07304843A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive DysfunctionUmecrine Cognition AB · PI: Pernilla Sandwall
- RECRUITINGPhase 3NCT05751967Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary CholangitisXijing Hospital of Digestive Diseases · PI: Ying Han, Doctor
- RECRUITINGPHASE2, PHASE3NCT05749822Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary CholangitisXijing Hospital of Digestive Diseases · PI: Ying Han
- RECRUITINGPhase 2NCT05050136A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary CholangitisMirum Pharmaceuticals, Inc.
- RECRUITINGNCT04514965Bezafibrate in Patients With Primary Biliary Cholangitis (PBC)University of Aarhus · PI: Henning Grønbæk, Prof, MD
- ACTIVE NOT RECRUITINGPhase 3NCT04526665Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)Ipsen · PI: Ipsen Medical Director
- RECRUITINGPhase 4NCT04650243Clinical Research of Tapering UDCA in PBC Patients With a Complete ResponsePeking Union Medical College Hospital · PI: Li Wang
- RECRUITINGNCT05151809National Database on Primary Biliary CholangitisUniversity of Milano Bicocca
- ACTIVE NOT RECRUITINGPhase 3NCT03301506Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)Gilead Sciences · PI: Gilead Study Director
- RECRUITINGPHASE2, PHASE3NCT06365424Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)Xijing Hospital of Digestive Diseases
- RECRUITINGNCT03146910Swiss Primary Biliary Cholangitis Cohort StudyFondazione Epatocentro Ticino
- RECRUITINGNCT02931513sCD163 in PBC Patients - Assessment of Treatment ResponseUniversity of Aarhus
- ACTIVE NOT RECRUITINGNCT02924701sCD163 in PBC Patients - Assessment of Disease Severity and PrognosisUniversity of Aarhus
- RECRUITINGNCT06767605Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)Asociación Española para el Estudio del Hígado · PI: Maria Carlota Londoño Londoño